Alpha Teknova (TKNO) Preferred Stock Liabilities (2020)

Alpha Teknova's (TKNO) quarterly Preferred Stock Liabilities came in at $35.6 million in Q4 2020.

Alpha Teknova (TKNO) Preferred Stock Liabilities (2020) Analysis & Trends

Alpha Teknova (TKNO) has 1 years of Preferred Stock Liabilities data on file, last reported at $35.6 million in Q4 2020.

On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $35.6 million in Q4 2020; TTM through Dec 2020 was $35.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $35.6 million, changed N/A from the prior year.
Preferred Stock Liabilities for Q4 2020 stood at $35.6 million.
Over the last five years, Preferred Stock Liabilities for TKNO reached as high as $35.6 million in Q4 2020 and fell as low as $35.6 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Alpha Teknova	278.75 Mn	260.97 Mn	3.78 Mn	-

Download Data

Date	Value
Dec 31, 2020	35.64 Mn